GATA6 and pulmonary arterial hypertension: Supporting previous observations, immunohistochemical and immunoblot analysis demonstrated reduced levels of GATA6 in both PAEC and PASMC in small remodeled PAs from patients with PAH (Fig. 2A) and in early-passage distal human IPAH PAEC and PASMC (Fig. 2B,C).